-

Shareholder Alert: Robbins LLP Announces Energy Recovery, Inc. (ERII) Accused of Misleading Shareholders

SAN DIEGO & SAN LEANDRO, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Energy Recovery, Inc. (NASDAQ: ERII) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between August 2, 2017 and June 29, 2020. Energy Recovery designs, manufactures, and markets various solutions for water desalination worldwide.

If you suffered a loss as a result of Energy Recovery's misconduct, click here.

Energy Recovery, Inc. (ERII) Accused of Misleading Shareholders

According to the complaint, in October 2015, Energy Recovery announced the signing of a fifteen-year deal with Schlumberger Technology Corp. (“Schlumberger”) in which Schlumberger received the exclusive right to the use of Energy Recovery's VorTeq technology for a $75 million exclusivity fee as well as additional $50 million milestone payments in 2016. Energy Recovery depended upon this deal for the commercialization of its VorTeq technology and to secure a stream of revenue, which was projected to reach $12 to $14 million in 2020. Throughout the relevant period, Energy Recovery continued to tout that the commercialization of VorTeq was on track, and as late as May 2020, the Company reiterated their expectation of reaching $12 to $14 million in license revenue. Despite assurances, on June 29, 2020, Energy Recovery announced the early termination of its Schlumberger License Agreement citing "different strategic perspectives as to the path to VorTeq commercialization.” Energy Recovery went on further to detail that all payments between the parties would cease and Energy Recovery would now be solely responsible for VorTeq's global commercialization. On this news, shares of Energy Recovery fell almost 16% to close at $7.59 per share.

If you purchased Energy Recovery, Inc. (ERII) securities between August 2, 2017 and June 29, 2020, you have until September 21, 2020, to ask the court to be appointed lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Energy Recovery settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:ERII

Release Versions
$Cashtags

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom